Connectus Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,396
Closed -$2.56M 392
2023
Q4
$2.56M Sell
5,396
-3,490
-39% -$1.61M 0.05% 227
2023
Q3
$3.89M Sell
8,886
-363
-4% -$165K 0.09% 188
2023
Q2
$4.13M Sell
9,249
-211
-2% -$97.3K 0.1% 157
2023
Q1
$4.36M Buy
9,460
+6,505
+220% +$3.1M 0.11% 146
2022
Q4
$1.52M Sell
2,955
-292
-9% -$148K 0.04% 233
2022
Q3
$1.48M Buy
3,247
+236
+8% +$113K 0.03% 285
2022
Q2
$1.46M Buy
3,011
+633
+27% +$313K 0.03% 228
2022
Q1
$1.1M Sell
2,378
-242
-9% -$111K 0.04% 232
2021
Q4
$1.22M Buy
+2,620
New +$1.1M 0.05% 193

Other funds holding ELV

Connectus Wealth's ELV Position: Q1 2024 in Review

Connectus Wealth sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 5,396 shares — an estimated $2.56M sold.

Connectus Wealth first reported a position in ELV in Q4 2021 and held it in 9 quarters. The position peaked at $4.36M in Q1 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Connectus Wealth reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Connectus Wealth sold 5,396 Elevance Health shares in Q1 2024, an estimated $2.56M.
  • Connectus Wealth first reported a position in Elevance Health in Q4 2021 and held it in 9 quarters.
  • Connectus Wealth's Elevance Health position peaked at $4.36M in Q1 2023.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.